Literature DB >> 20101600

Cannabinoids alter spontaneous firing, bursting, and cell synchrony of hippocampal principal cells.

Anushka V Goonawardena1, Gernot Riedel, Robert E Hampson.   

Abstract

Both natural and synthetic cannabinoid receptor (e.g., CB1) agonists such as Δ(9)-THC, WIN 55,212-2 (WIN-2), and HU-210 disrupt spatial cognition presumably through the inhibition of synchrony of hippocampal ensemble firing to task-related events. Although the CB1 receptor agonist CP 55,940 also disrupts the synchronous firing of hippocampal neurons, it does not seem to affect the average firing rate. This difference is not readily explained by the chemical structure and pharmacology of the different compounds thus warranting a more detailed examination into (i) how other cannabinoids affect the spontaneous firing, bursting, and cell synchrony of hippocampal principal cells located in CA3 and CA1 subfields, and (ii) whether these effects are indeed mediated through CB1 receptors, which will be explored by the selective antagonist AM-251. Male Long-Evans rats surgically implanted with multielectrode arrays to hippocampal CA3 and CA1 were anesthetized and principal cells discharging at 0.25-6.0 Hz were isolated and "tracked" following the systemic administration of Tween-80, Δ(9)-THC (1 or 3 mg/kg) or WIN-2 (1 mg/kg) or HU-210 (100 μg/kg), and 1.5 mg/kg AM-281. All cannabinoids except for 1 mg/kg Δ(9) -THC reliably reduced average firing rates and altered "burst" characteristics, which were reversible with AM-281 for Δ(9)-THC and WIN-2 but not for HU-210. In addition, all cannabinoids disrupted intrasubfield and intersubfield ensemble synchrony of pyramidal cells, which is an effect insensitive to AM-281 and thus unlikely to be CB1 mediated. We consider these cannabinoid effects on spike timing and firing/bursting of principal hippocampal neurons carried by CB1 and non-CB1 receptors to be physiological underpinnings of the cognitive impairments inherent to cannabinoid exposure.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20101600      PMCID: PMC3126104          DOI: 10.1002/hipo.20769

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  63 in total

1.  Reversible neural inactivation reveals hippocampal participation in several memory processes.

Authors:  G Riedel; J Micheau; A G Lam; E L Roloff; S J Martin; H Bridge; L de Hoz; B Poeschel; J McCulloch; R G Morris
Journal:  Nat Neurosci       Date:  1999-10       Impact factor: 24.884

2.  Temporal interaction between single spikes and complex spike bursts in hippocampal pyramidal cells.

Authors:  K D Harris; H Hirase; X Leinekugel; D A Henze; G Buzsáki
Journal:  Neuron       Date:  2001-10-11       Impact factor: 17.173

Review 3.  Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids.

Authors:  J M Sullivan
Journal:  Learn Mem       Date:  2000 May-Jun       Impact factor: 2.460

4.  Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices.

Authors:  A N Gifford; Y Tang; S J Gatley; N D Volkow; R Lan; A Makriyannis
Journal:  Neurosci Lett       Date:  1997-11-28       Impact factor: 3.046

5.  Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state.

Authors:  P T Huerta; J E Lisman
Journal:  Nature       Date:  1993-08-19       Impact factor: 49.962

6.  Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.

Authors:  A N Gifford; C R Ashby
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

Review 7.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

8.  Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons.

Authors:  Robert E Hampson; John D Simeral; Erica J Kelly; Sam A Deadwyler
Journal:  Hippocampus       Date:  2003       Impact factor: 3.899

9.  Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.

Authors:  G L Gessa; M A Casu; G Carta; M S Mascia
Journal:  Eur J Pharmacol       Date:  1998-08-21       Impact factor: 4.432

10.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.

Authors:  M Herkenham; A B Lynn; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  J Neurosci       Date:  1991-02       Impact factor: 6.167

View more
  14 in total

1.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

2.  Modulation by pregnenolone sulfate of filtering properties in the hippocampal trisynaptic circuit.

Authors:  Chessa S Scullin; L Donald Partridge
Journal:  Hippocampus       Date:  2012-05-31       Impact factor: 3.899

3.  Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat.

Authors:  Anushka V Goonawardena; Lianne Robinson; Robert E Hampson; Gernot Riedel
Journal:  Learn Mem       Date:  2010-09-28       Impact factor: 2.460

4.  Effect fingerprints of antipsychotic drugs on neural networks in vitro.

Authors:  Philipp Görtz; Uwe Henning; Stephan Theiss; Christian Lange-Asschenfeldt
Journal:  J Neural Transm (Vienna)       Date:  2019-07-18       Impact factor: 3.575

5.  Learning by subtraction: Hippocampal activity and effects of ethanol during the acquisition and performance of response sequences.

Authors:  Myles J Ketchum; Theodore G Weyand; Peter F Weed; Peter J Winsauer
Journal:  Hippocampus       Date:  2015-11-05       Impact factor: 3.899

6.  Parvalbumin-containing GABA cells and schizophrenia: experimental model based on targeted gene delivery through adeno-associated viruses.

Authors:  Marta U Woloszynowska-Fraser; Peer Wulff; Gernot Riedel
Journal:  Behav Pharmacol       Date:  2017-12       Impact factor: 2.293

7.  Chronic adolescent exposure to ∆9-tetrahydrocannabinol decreases NMDA current and extrasynaptic plasmalemmal density of NMDA GluN1 subunits in the prelimbic cortex of adult male mice.

Authors:  Virginia M Pickel; Faye Bourie; June Chan; Ken Mackie; Diane A Lane; Gang Wang
Journal:  Neuropsychopharmacology       Date:  2019-07-19       Impact factor: 7.853

8.  Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors.

Authors:  Robert E Hampson; Andrew J Sweatt; Anushka V Goonawardena; Dong Song; Rosa H M Chan; Vasilis Z Marmarelis; Theodore W Berger; Sam A Deadwyler
Journal:  Behav Pharmacol       Date:  2011-08       Impact factor: 2.293

9.  Multifractal analysis of information processing in hippocampal neural ensembles during working memory under Δ⁹-tetrahydrocannabinol administration.

Authors:  Dustin Fetterhoff; Ioan Opris; Sean L Simpson; Sam A Deadwyler; Robert E Hampson; Robert A Kraft
Journal:  J Neurosci Methods       Date:  2014-07-30       Impact factor: 2.390

10.  WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction.

Authors:  Lianne Robinson; Anushka V Goonawardena; Roger Pertwee; Robert E Hampson; Bettina Platt; Gernot Riedel
Journal:  Behav Brain Res       Date:  2010-01-14       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.